Eason Hahm

Director, BioPharma

William Blair

Bio:

Eason Hahm joined William Blair in 2012 and is a Director within the healthcare investment banking group, focused on biopharma. Eason has over 14 years of experience and has completed over 100 M&A and financing transactions.

Eason received an AB in Biomedical Engineering from Harvard College and an MBA in Health Care Management from the Wharton School of the University of Pennsylvania.

Sessions:

Speaker The Capital Decision — When (and Whether) to Go Public in Today’s Biotech Market